Ligand Binding and Activation of the Ah Receptor

Total Page:16

File Type:pdf, Size:1020Kb

Ligand Binding and Activation of the Ah Receptor Chemico-Biological Interactions 141 (2002) 3Á/24 www.elsevier.com/locate/chembiont Ligand binding and activation of the Ah receptor Michael S. Denison a,*, Alessandro Pandini c, Scott R. Nagy a, Enoch P. Baldwin b, Laura Bonati c a Department of Environmental Toxicology, Meyer Hall, One Shields Avenue, University of California, Davis, CA 95616-8588, USA b Section of Molecular and Cellular Biology, Briggs Hall, University of California, Davis, CA 95616, USA c Dipartimento di Scienze dell’Ambiente e del Territorio, Universita` degli Studi di Milano-Bicocca, Piazza della Scienza, 1-20126 Milano, Italy Abstract The Ah receptor (AhR) is a ligand-dependent transcription factor that can be activated by structurally diverse synthetic and naturally-occurring chemicals. Although a significant amount of information is available with respect to the planar aromatic hydrocarbon AhR ligands, the actual spectrum of chemicals that can bind to and activate the AhR is only now being elucidated. In addition, the lack of information regarding the actual three-dimensional structure of the AhR ligand binding domain (LBD) has hindered detailed analysis of the molecular mechanisms by which these ligands bind to an active AhR signal transduction. In this review we describe the current state of knowledge with respect to naturally occurring AhR ligands and present and discuss the first theoretical model of the AhR LBD based on crystal structures of homologous PAS family members. # 2002 Elsevier Science Ireland Ltd. All rights reserved. Keywords: Ah receptor; 2,3,7,8-Tetrachlorodibenzo-p-dioxin; TCDD; Dioxin; Homology model; Ligand binding domain Abbreviations: AA, arachidonic acid; AhR, aryl hydrocarbon receptor; ARNT, AhR nuclear translocator; bHLH, basic helixÁ/loopÁ/helix; BNF, b-naphthoflavone; CYP1A1, cytochrome P4501A1; HAH, halogenated aromatic hydrocarbon; ICZ, indolo-[3,2,-b]-carbazole; LBD, ligand binding domain; NLS, nuclear localization sequence; PAH, polycyclic aromatic hydrocarbon; PAS, PerÁ/ArntÁ/Sim; PCDD, polychlorinated dibenzo-p-dioxin; PGG2, prostaglandin G2 PYP, photoactive yellow protein; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; TRP, tryptophan; XAP2, X-associated protein 2. * Corresponding author. Tel.: /1-530-752-3879; fax: /1-530-752-3394 E-mail address: [email protected] (M.S. Denison). 0009-2797/02/$ - see front matter # 2002 Elsevier Science Ireland Ltd. All rights reserved. PII: S 0 0 0 9 - 2 7 9 7 ( 0 2 ) 0 0 0 6 3 - 7 4 M.S. Denison et al. / Chemico-Biological Interactions 141 (2002) 3Á/24 1. Introduction The Ah receptor (AhR) is a basic helixÁ/loopÁ/helix (bHLH)- and PerÁ/ArntÁ/Sim (PAS)-containing transcription factor that regulates the expression of genes in a ligand-dependent manner [1Á/4]. Although recent studies have demonstrated that the AhR can bind and be activated by a structurally diverse range of chemicals [5,6], the best characterized high affinity ligands for the AhR include a wide variety of ubiquitous and hydrophobic environmental contaminants [7,8] such as the haloge- nated aromatic hydrocarbons (HAHs) and the non-halogenated polycyclic aromatic hydrocarbons (PAHs). Exposure to numerous HAHs, including 2,3,7,8-tetrachlor- odibenzo-p-dioxin (TCDD, dioxin), the most potent member of this class of chemicals, produces a wide variety of species- and tissue-specific toxic and biological effects [7Á/11]. The induction of gene expression is one response observed in all species exposed to TCDD and related chemicals. Induction of expression of cytochrome P4501A1 (CYP1A1) has been used as a model system to define the mechanism of action of HAHs. Biochemical and genetic studies over the past 20 years has revealed that induction of CYP1A1 and other HAH/PAH-responsive genes, as well as the toxicity of TCDD and related HAHs, is mediated by the AhR, a soluble intracellular receptor to which these chemicals bind with high affinity [3,7,8,12]. Mechanistically, the inducing chemical diffuses across the plasma membrane and binds to the AhR which is present in the cytosolic compartment as a multiprotein complex containing two molecules of hsp90 (a heat shock protein of 90 kDa), the X-associated protein 2 (XAP2 [13]) (also referred to as AIP or ara9 [14,15]) and p23 (a co-chaperone protein of 23 kDa [16]). Following ligand binding, the cytosolic ligand:AhR complex is presumed to undergo a conformation change exposing a nuclear localization sequence(s) (NLS(s)). The complex then translocates into the nucleus [17,18], dissociates from the protein complex and binds to a closely related nuclear bHLHÁ/PAS protein called Arnt (AhR nuclear translocator [1]). Formation of the AhR:Arnt heterodimer converts the complex into its high affinity DNA binding form [1,19] and binding of the complex to its specific DNA recognition site, the dioxin responsive element (DRE), upstream of the CYP1A1 gene leads to chromatin and nucleosome disruption, increased promoter accessibility and an increase in transcription of the CYP1A1 gene [12,20Á/22]. DREs have also been identified in the upstream region of most other TCDD-inducible genes [3] and they also appear to be responsible for conferring TCDD- and AhR-responsiveness upon these genes. The presence of the AhR and AhR signal transduction pathway in a diverse range of species, tissues and cell types [23Á/27] and its ability to act as a ligand-dependent transcription factor suggests that many of the toxic and biological effects of AhR ligands result from differential alteration of gene expression in susceptible cells. In addition, since the majority of the toxic effects of TCDD/HAHs are not observed until weeks following chemical exposure [7,11], the adverse effects of these chemicals likely result from the continuous and inappropriate expression of specific genes in target cells which ultimately results in the delayed toxic responses. Although significant advances in the field over the past 10 years have clearly defined the role of AhR in the toxic and biological effects of AhR ligands, the exact M.S. Denison et al. / Chemico-Biological Interactions 141 (2002) 3Á/24 5 biochemical events which lead to the spectrum of species- and tissue-specific toxic responses to these chemicals still remain elusive. All of the high affinity AhR ligands identified to date (HAHs and PAHs) are planar hydrophobic molecules and are able to induce gene expression in an AhR- dependent manner. In previous reviews [5,6], we detailed the spectrum of chemicals that have been documented in the literature to bind to and active the AhR- and/or induce AhR-dependent gene expression. Accordingly, rather than reiterating what we have described previously, this review will highlight more recent developments in our knowledge about AhR ligands with an emphasis on naturally occurring ligands that activate the AhR and AhR signaling pathway. In addition, we will describe reported differences in AhR ligand binding specificity between species and describe recent structural modeling studies of the AhR ligand binding domain (LBD) itself. For a more in depth description of AhR signal transduction and the effects of AhR ligands, the reader is referred both to additional reviews contained within this special issue of Chemico-Biological Interactions and to the many excellent published reviews [1Á/3,5,7,11,12,28]. 2. AhR ligands HAHs (such as the polychlorinated dibenzo-p-dioxins (PCDDs), dibenzofurans and biphenyls and related chemicals) and the PAHs (such as benzo(a)pyrene, 3- methylcholanthrene, benzoflavones, rutacarpine alkaloids, aromatic amines and related chemicals) are the most extensively studied classes of AhR ligands [5,7,8,29Á/ 32]. HAHs have a relatively high binding affinity for the AhR (in the pM to nM range) whereas the PAHs have a significantly lower affinity (in the high nM to mM range). StructureÁ/activity relationship studies with a large number of HAH and PAH AhR ligands suggest that the AhR binding pocket can accept planar ligands with maximal dimensions of 14/12/5 A˚ . However, high affinity binding appears to be critically dependent upon key thermodynamic and electronic properties of the ligands [29Á/37]. The overall picture emerging from these studies highlights the role of electrostatic and dispersion-type interactions in ligandÁ/AhR binding. Although the results of these modeling studies have some predictive applications for identification of new high affinity AhR ligands, the constraints of these models are too restrictive, especially given that a large number of chemicals that are reported to bind the AhR have physicochemical and structural properties that deviate significantly from the currently defined structural requirements for AhR ligands (reviewed in Refs. [5,6]). Although the majority of these chemicals are relatively weak inducers or AhR ligands when compared with TCDD, their striking structural diversity is clearly evidenced by comparison of the chemicals for which direct AhR binding has been demonstrated (Fig. 1). While binding remains to be demonstrated for many of these structurally diverse AhR activators [5], their ability to induce CYP1A1 and/or activate the AhR- and AhR-dependent gene expression is consistent with their ability to interact with the AhR. Because most of these chemicals do not fit 6 M.S. Denison et al. / Chemico-Biological Interactions 141 (2002) 3Á/24 Fig. 1. Structures of selected AhR ligands. See text and Denison et al. [5] for more details. the established characteristics for known AhR ligands, their identification as ligands supports a reevaluation of the currently accepted
Recommended publications
  • The Aryl Hydrocarbon Receptor: Structural Analysis and Activation Mechanisms
    The Aryl Hydrocarbon Receptor: Structural Analysis and Activation Mechanisms This thesis is submitted in fulfilment of the requirements for the degree of Doctor of Philosophy in the School of Molecular and Biomedical Sciences (Biochemistry), The University of Adelaide, Australia Fiona Whelan, B.Sc. (Hons) 2009 2 Table of Contents THESIS SUMMARY................................................................................. 6 DECLARATION....................................................................................... 7 PUBLICATIONS ARISING FROM THIS THESIS.................................... 8 ACKNOWLEDGEMENTS...................................................................... 10 ABBREVIATIONS ................................................................................. 12 CHAPTER 1: INTRODUCTION ............................................................. 17 1.1 BHLH.PAS PROTEINS ............................................................................................17 1.1.1 General background..................................................................................17 1.1.2 bHLH.PAS Class I Proteins.........................................................................18 1.2 THE ARYL HYDROCARBON RECEPTOR......................................................................19 1.2.1 Domain Structure and Ligand Activation ..............................................19 1.2.2 AhR Expression and Developmental Activity .......................................21 1.2.3 Mouse AhR Knockout Phenotype ...........................................................23
    [Show full text]
  • R Graphics Output
    Dexamethasone sodium phosphate ( 0.339 ) Melengestrol acetate ( 0.282 ) 17beta−Trenbolone ( 0.252 ) 17alpha−Estradiol ( 0.24 ) 17alpha−Hydroxyprogesterone ( 0.238 ) Triamcinolone ( 0.233 ) Zearalenone ( 0.216 ) CP−634384 ( 0.21 ) 17alpha−Ethinylestradiol ( 0.203 ) Raloxifene hydrochloride ( 0.203 ) Volinanserin ( 0.2 ) Tiratricol ( 0.197 ) trans−Retinoic acid ( 0.192 ) Chlorpromazine hydrochloride ( 0.191 ) PharmaGSID_47315 ( 0.185 ) Apigenin ( 0.183 ) Diethylstilbestrol ( 0.178 ) 4−Dodecylphenol ( 0.161 ) 2,2',6,6'−Tetrachlorobisphenol A ( 0.156 ) o,p'−DDD ( 0.155 ) Progesterone ( 0.152 ) 4−Hydroxytamoxifen ( 0.151 ) SSR150106 ( 0.149 ) Equilin ( 0.3 ) 3,5,3'−Triiodothyronine ( 0.256 ) 17−Methyltestosterone ( 0.242 ) 17beta−Estradiol ( 0.24 ) 5alpha−Dihydrotestosterone ( 0.235 ) Mifepristone ( 0.218 ) Norethindrone ( 0.214 ) Spironolactone ( 0.204 ) Farglitazar ( 0.203 ) Testosterone propionate ( 0.202 ) meso−Hexestrol ( 0.199 ) Mestranol ( 0.196 ) Estriol ( 0.191 ) 2,2',4,4'−Tetrahydroxybenzophenone ( 0.185 ) 3,3,5,5−Tetraiodothyroacetic acid ( 0.183 ) Norgestrel ( 0.181 ) Cyproterone acetate ( 0.164 ) GSK232420A ( 0.161 ) N−Dodecanoyl−N−methylglycine ( 0.155 ) Pentachloroanisole ( 0.154 ) HPTE ( 0.151 ) Biochanin A ( 0.15 ) Dehydroepiandrosterone ( 0.149 ) PharmaCode_333941 ( 0.148 ) Prednisone ( 0.146 ) Nordihydroguaiaretic acid ( 0.145 ) p,p'−DDD ( 0.144 ) Diphenhydramine hydrochloride ( 0.142 ) Forskolin ( 0.141 ) Perfluorooctanoic acid ( 0.14 ) Oleyl sarcosine ( 0.139 ) Cyclohexylphenylketone ( 0.138 ) Pirinixic acid ( 0.137 )
    [Show full text]
  • Open Thesis Master Document V5.0.Pdf
    The Pennsylvania State University The Graduate School Department of Veterinary and Biomedical Science IDENTIFICATION OF ENDOGENOUS MODULATORS FOR THE ARYL HYDROCARBON RECEPTOR A Thesis in Genetics by Christopher R. Chiaro © 2007 Christopher R. Chiaro Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy December, 2007 The thesis of Christopher R. Chiaro was reviewed and approved* by the following: Gary H. Perdew John T. and Paige S. Smith Professor in Agricultural Sciences Thesis Advisor Chair of Committee C. Channa Reddy Distinguished Professor of Veterinary Science A. Daniel Jones Senior Scientist Department of Chemistry John P. Vanden Heuvel Professor of Veterinary Science Richard Ordway Associate Professor of Biology Chair of Genetics Graduate Program *Signatures are on file in the Graduate School iii ABSTRACT The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor capable of being regulated by a structurally diverse array of chemicals ranging from environmental carcinogens to dietary metabolites. A member of the basic helix-loop- helix/ Per-Arnt-Sim (bHLH-PAS) super-family of DNA binding regulatory proteins, the AhR is an important developmental regulator that can be detected in nearly all mammalian tissues. Prior to ligand activation, the AhR resides in the cytosol as part of an inactive oligomeric protein complex comprised of the AhR ligand-binding subunit, a dimer of the 90 kDa heat shock protein, and a single molecule each of the immunophilin like X-associated protein 2 (XAP2) and p23 proteins. Functioning as chemosensor, the AhR responds to both endobiotic and xenobiotic derived chemical ligands by ultimately directing the expression of metabolically important target genes.
    [Show full text]
  • Chlorinated and Polycyclic Aromatic Hydrocarbons in Riverine and Estuarine Sediments from Pearl River Delta, China
    Environmental Pollution 117 (2002) 457–474 www.elsevier.com/locate/envpol Chlorinated and polycyclic aromatic hydrocarbons in riverine and estuarine sediments from Pearl River Delta, China Bi-Xian Maia,*, Jia-Mo Fua, Guo-Ying Shenga, Yue-Hui Kanga, Zheng Lina, Gan Zhanga, Yu-Shuan Mina, Eddy Y. Zengb aState Key Lab Laboratory of Organic Geochemistry, Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, PO Box 1130, Guangzhou, Guangdong 510640, People’s Republic of China bSouthern California Coastal Water Research Project, 7171 Fenwick Lane, Westminster, CA 92683, USA Received 5 January 2001; accepted 3 July 2001 ‘‘Capsule’’: Sediments of the Zhujiang River and Macao Harbor have the potential to be detrimental to biological systems. Abstract Spatial distribution of chlorinated hydrocarbons [chlorinated pesticides (CPs) and polychlorinated biphenyls (PCBs)] and poly- cyclic aromatic hydrocarbons (PAHs) was measured in riverine and estuarine sediment samples from Pearl River Delta, China, collected in 1997. Concentrations of CPs of the riverine sediment samples range from 12 to 158 ng/g, dry weight, while those of PCBs range from 11 to 486 ng/g. The CPs concentrations of the estuarine sediment samples are in the range 6–1658 ng/g, while concentrations of PCBs are in the range 10–339 ng/g. Total PAH concentration ranges from 1168 to 21,329 ng/g in the riverine sediment samples, whereas the PAH concentration ranges from 323 to 14,812ng/g in the sediment samples of the Estuary. Sediment samples of the Zhujiang River and Macao harbor around the Estuary show the highest concentrations of CPs, PCBs, and PAHs. Possible factors affecting the distribution patterns are also discussed based on the usage history of the chemicals, hydrologic con- dition, and land erosion due to urbanization processes.
    [Show full text]
  • Epigenetic Regulations of Ahr in the Aspect of Immunomodulation
    International Journal of Molecular Sciences Review Epigenetic Regulations of AhR in the Aspect of Immunomodulation Anna Wajda 1,* , Joanna Łapczuk-Roma ´nska 2 and Agnieszka Paradowska-Gorycka 1 1 Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland; [email protected] 2 Department of Experimental and Clinical Pharmacology, Pomeranian Medical University, 70-111 Szczecin, Poland; [email protected] * Correspondence: [email protected] Received: 31 July 2020; Accepted: 28 August 2020; Published: 3 September 2020 Abstract: Environmental factors contribute to autoimmune disease manifestation, and as regarded today, AhR has become an important factor in studies of immunomodulation. Besides immunological aspects, AhR also plays a role in pharmacological, toxicological and many other physiological processes such as adaptive metabolism. In recent years, epigenetic mechanisms have provided new insight into gene regulation and reveal a new contribution to autoimmune disease pathogenesis. DNA methylation, histone modifications, chromatin alterations, microRNA and consequently non-genetic changes in phenotypes connect with environmental factors. Increasing data reveals AhR cross-roads with the most significant in immunology pathways. Although study on epigenetic modulations in autoimmune diseases is still not well understood, therefore future research will help us understand their pathophysiology and help to find new therapeutic strategies. Present literature review
    [Show full text]
  • Independent Actions on Cyclin-Dependent Kinases and Aryl Hydrocarbon Receptor Mediate the Antiproliferative Effects of Indirubins
    Oncogene (2004) 23, 4400–4412 & 2004 Nature Publishing Group All rights reserved 0950-9232/04 $30.00 www.nature.com/onc Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins Marie Knockaert1, Marc Blondel1, Ste´ phane Bach1, Maryse Leost1, Cem Elbi2, Gordon L Hager2, Scott RNagy 3, Dalho Han3, Michael Denison3, Martine Ffrench4, Xiaozhou P Ryan5, Prokopios Magiatis6, Panos Polychronopoulos6, Paul Greengard5, Leandros Skaltsounis6 and Laurent Meijer*,1,5 1C.N.R.S., Cell Cycle Group & UPS-2682, Station Biologique, BP 74, 29682 ROSCOFF cedex, Bretagne, France; 2Laboratory of Receptor Biology & Gene Expression, Bldg 41, Room B602, National Cancer Institute, NIH, Bethesda, MD 20892-5055, USA; 3Department of Environmental Toxicology, Meyer Hall, One Shields Avenue, University of California, Davis, CA 95616-8588, USA; 4Universite´ Claude Bernard, Laboratoire de Cytologie Analytique et Cytoge´ne´tique Mole´culaire, 8 Avenue Rockefeller, 69373 Lyon Cedex 08, France; 5Laboratory of Molecular & Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA; 6Division of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, University of Athens, Panepistimiopolis Zografou, GR-15771 Athens, Greece Indirubin, a bis-indole obtained from various natural Introduction sources, is responsible for the reported antileukemia activity of a Chinese Medicinal recipe, Danggui Longhui The bis-indole indirubin has been identified as the main Wan. However, its molecular mechanism of action is still active ingredient of a traditional Chinese medicinal not well understood. In addition to inhibition of cyclin- recipe, Danggui Longhui Wan, used to treat various dependent kinases and glycogen synthase kinase-3, diseases including chronic myelocytic leukemia (reviews indirubins have been reported to activate the aryl in Tang and Eisenbrand, 1992; Xiao et al., 2002).
    [Show full text]
  • Dibenzofuran, 4-Chromanone, Acetophenone, and Dithiecine Derivatives: Cytotoxic Constituents from Eupatorium Fortunei
    International Journal of Molecular Sciences Article Dibenzofuran, 4-Chromanone, Acetophenone, and Dithiecine Derivatives: Cytotoxic Constituents from Eupatorium fortunei Chun-Hao Chang 1, Semon Wu 2, Kai-Cheng Hsu 3,4, Wei-Jan Huang 5,6 and Jih-Jung Chen 7,8,9,* 1 Institute of Biopharmaceutical Sciences, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan; [email protected] 2 Department of Life Science, Chinese Culture University, Taipei 110, Taiwan; [email protected] 3 Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan; [email protected] 4 Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan 5 Ph.D. Program in Biotechnology Research and Development, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan; [email protected] 6 Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan 7 Department of Pharmacy, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan 8 Faculty of Pharmacy, National Yang-Ming University, Taipei 112, Taiwan 9 Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan * Correspondence: [email protected]; Tel.: +886-2-2826-7195; Fax: +886-2-2823-2940 Abstract: Five new compounds, eupatodibenzofuran A (1), eupatodibenzofuran B (2), 6-acetyl-8- methoxy-2,2-dimethylchroman-4-one (3), eupatofortunone (4), and eupatodithiecine (5), have been isolated from the aerial part of Eupatorium fortunei, together with 11 known compounds (6-16).
    [Show full text]
  • Detection, Occurrence and Fate of Indirubin in Municipal Sewage
    Subscriber access provided by BEIJING UNIV Article Detection, Occurrence and Fate of Indirubin in Municipal Sewage Treatment Plants Jianying Hu, Hong Chang, Lezheng Wang, Shimin Wu, Bin Shao, Jun Zhou, and Ying Zhao Environ. Sci. Technol., 2008, 42 (22), 8339-8344• DOI: 10.1021/es801038y • Publication Date (Web): 11 October 2008 Downloaded from http://pubs.acs.org on March 12, 2009 More About This Article Additional resources and features associated with this article are available within the HTML version: • Supporting Information • Access to high resolution figures • Links to articles and content related to this article • Copyright permission to reproduce figures and/or text from this article Environmental Science & Technology is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Environ. Sci. Technol. 2008, 42, 8339–8344 to cause liver damage, growth retardation, certain types of Detection, Occurrence and Fate of cancer, birth defects, depression of immunological function, Indirubin in Municipal Sewage and reproductive problems in several species by binding to activating aryl hydrocarbon receptor (AhR) (3-6). These AhR Treatment Plants agonists have been identified in almost every component of the global ecosystem including fish, wildlife, human adipose tissue, milk, and serum (7). JIANYING HU,*,† HONG CHANG,† LEZHENG WANG,† SHIMIN WU,† Besides these chemicals, a wide variety of naturally BIN SHAO,‡ JUN ZHOU,§ AND occurring chemicals such as tetrapyroles, indoles, and YING ZHAO§ arachidonic acid metabolites have been also reported to be College of Urban and Environmental Science, Peking AhR agonists (8, 9). Some of these chemicals were reported University, Beijing 100871, China, Institute of Nutrition and to interact with AhR and produce activation or inhibition of Food Hygiene, Beijing Center for Disease Prevention and signal transduction.
    [Show full text]
  • Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome
    International Journal of Molecular Sciences Review Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome Stefano Turolo 1,* , Alberto Edefonti 1 , Alessandra Mazzocchi 2, Marie Louise Syren 2, William Morello 1, Carlo Agostoni 2,3 and Giovanni Montini 1,2 1 Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, Pediatric Nephrology, Dialysis and Transplant Unit, Via della Commenda 9, 20122 Milan, Italy; [email protected] (A.E.); [email protected] (W.M.); [email protected] (G.M.) 2 Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy; [email protected] (A.M.); [email protected] (M.L.S.); [email protected] (C.A.) 3 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Pediatric Intermediate Care Unit, 20122 Milan, Italy * Correspondence: [email protected] Abstract: Studies concerning the role of arachidonic acid (AA) and its metabolites in kidney disease are scarce, and this applies in particular to idiopathic nephrotic syndrome (INS). INS is one of the most frequent glomerular diseases in childhood; it is characterized by T-lymphocyte dysfunction, alterations of pro- and anti-coagulant factor levels, and increased platelet count and aggregation, leading to thrombophilia. AA and its metabolites are involved in several biological processes. Herein, Citation: Turolo, S.; Edefonti, A.; we describe the main fields where they may play a significant role, particularly as it pertains to their Mazzocchi, A.; Syren, M.L.; effects on the kidney and the mechanisms underlying INS. AA and its metabolites influence cell Morello, W.; Agostoni, C.; Montini, G.
    [Show full text]
  • Bilirubin and Beyond: a Review of Lipid Status in Gilbert's Syndrome and Its Relevance to Cardiovascular Disease Protection
    Bilirubin and beyond: A review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection Author Bulmer, AC, Verkade, HJ, Wagner, K-H Published 2013 Journal Title Progress in Lipid Research DOI https://doi.org/10.1016/j.plipres.2012.11.001 Copyright Statement © 2013 Elsevier. This is the author-manuscript version of this paper. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version. Downloaded from http://hdl.handle.net/10072/54228 Griffith Research Online https://research-repository.griffith.edu.au Bilirubin and beyond: a review of lipid status in Gilbert’s syndrome and its relevance to cardiovascular disease protection Bulmer, A.C.1*, Verkade, H.J.2, Wagner, K-H3* 1Heart Foundation Research Centre, Griffith Health Institute, Griffith University, Gold Coast, Australia. 2Pediatric Gastroenterology – Hepatology, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, The Netherlands. 3Emerging Field Oxidative Stress and DNA Stability, Department of Nutritional Sciences, University of Vienna, Vienna, Austria. *Corresponding Authors Prof Karl-Heinz Wagner Department of Nutritional Sciences Althanstrasse 14, 1090, Vienna, Austria Ph: +43 1 427754930 Fax: +43 1 42779549 Dr Andrew Bulmer Heart Foundation Research Centre Griffith Health Institute Griffith University Parklands Avenue, Southport, Southport, 4222, Australia Ph: +61 7 55528215 Fax: +61 7 5552 8908 1 Abstract Gilbert’s syndrome (GS) is characterized by a benign, mildly elevated bilirubin concentration in the blood. Recent reports show clear protection from cardiovascular disease in this population. Protection of lipids, proteins and other macromolecules from oxidation by bilirubin represents the most commonly accepted mechanism contributing to protection in this group.
    [Show full text]
  • Cyclooxygenase Pathway
    Cyclooxygenase Pathway Diverse physical, chemical, Phospholipase A Glucocorticoids inflammatory, and 2 mitogenic stimuli NSAIDs NSAIDs Arachidonic Acid Prostaglandin G2 CYCLOOXYGENASE Prostaglandin G2 Prostaglandin H Prostaglandin H Synthase-1 Synthase-2 (COX 1) (COX 2) Prostaglandin H2 PEROXIDASE Prostaglandin H2 Tissue Specific Isomerases Prostacyclin Thromboxane A2 Prostaglandin D2 Prostaglandin E2 Prostaglandin F2α IP TPα, TPβ DP1, DP2 EP1, EP2, EP3, EP4 FPα, FPβ Endothelium, Kidney, Platelets, Vascular Mast Cells, Brain, Brain, Kidney, Vascular Uterus, Airways, Vascular Platelets, Brain Smooth Muscle Cells, Airways, Lymphocytes, Smooth Muscle Cells, Smooth Muscle Cells, Macrophages, Kidney Eosinophils Platelets Eyes Prostacyclin Item No. Product Features Prostacyclin (Prostaglandin I2; PGI2) is formed from arachidonic acid primarily in the vascular endothelium and renal cortex by sequential 515211 6-keto • Sample Types: Culture Medium | Plasma Prostaglandin • Measure 6-keto PGF levels down to 6 pg/ml activities of COX and prostacyclin synthase. PGI2 is non-enzymatically 1α F ELISA Kit • Incubation : 18 hours | Development: 90-120 minutes | hydrated to 6-keto PGF1α (t½ = 2-3 minutes), and then quickly converted 1α Read: Colorimetric at 405-420 nm to the major metabolite, 2,3-dinor-6-keto PGF1α (t½= 30 minutes). Prostacyclin was once thought to be a circulating hormone that regulated • Assay 24 samples in triplicate or 36 samples in duplicate platelet-vasculature interactions, but the rate of secretion into circulation • NOTE: A portion of urinary 6-keto PGF1α is of renal origin coupled with the short half-life indicate that prostacyclin functions • NOTE : It has been found that normal plasma levels of 6-keto PGF may be low locally.
    [Show full text]
  • Dioxin) Receptor
    TOXICOLOGICAL SCIENCES 124(1), 1–22 (2011) doi:10.1093/toxsci/kfr218 Advance Access publication September 9, 2011 Exactly the Same but Different: Promiscuity and Diversity in the Molecular Mechanisms of Action of the Aryl Hydrocarbon (Dioxin) Receptor Michael S. Denison,*,1 Anatoly A. Soshilov,* Guochun He,* Danica E. DeGroot,* and Bin Zhao† Downloaded from *Department of Environmental Toxicology, University of California, Davis, California 95616; and †Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China 1To whom correspondence should be addressed at Department of Environmental Toxicology, University of California, Meyer Hall, One Shields Avenue, Davis, CA 95616-8588. Fax: (530) 752-3394. E-mail: [email protected]. http://toxsci.oxfordjournals.org/ Received June 6, 2011; accepted August 12, 2011 toxic effects in a wide range of species and tissues (Beischlag The Ah receptor (AhR) is a ligand-dependent transcription et al., 2008; Furness and Whelan, 2009; Hankinson, 2005; factor that mediates a wide range of biological and toxicological Humblet et al., 2008; Marinkovic´ et al., 2010; Poland and effects that result from exposure to a structurally diverse variety Knutson, 1982; Safe, 1990; White and Birnbaum, 2009). The of synthetic and naturally occurring chemicals. Although the overall mechanism of action of the AhR has been extensively best-characterized high-affinity ligands for the AhR include at University of California, Davis - Library on May 4, 2012 studied and involves a classical nuclear receptor mechanism of a wide variety of ubiquitous hydrophobic environmental action (i.e., ligand-dependent nuclear localization, protein hetero- contaminants such as the halogenated aromatic hydrocarbons dimerization, binding of liganded receptor as a protein complex to (HAHs) and nonhalogenated polycyclic aromatic hydrocarbons its specific DNA recognition sequence and activation of gene (PAHs).
    [Show full text]